Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US - Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019.
Roberts MH, Mannino DM, Mapel DW, Lunacsek O, Amin S, Farrelly E, Feigler N, Pollack MF. Roberts MH, et al. Among authors: feigler n. Int J Chron Obstruct Pulmon Dis. 2024 May 13;19:1033-1046. doi: 10.2147/COPD.S446696. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38765766 Free PMC article.
Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study.
Strange C, Tkacz J, Schinkel J, Lewing B, Agatep B, Swisher S, Patel S, Edwards D, Touchette DR, Portillo E, Feigler N, Pollack M. Strange C, et al. Among authors: feigler n. Int J Chron Obstruct Pulmon Dis. 2023 Oct 12;18:2245-2256. doi: 10.2147/COPD.S432963. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37849918 Free PMC article.
Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program.
Kerr M, Tarabichi Y, Evans A, Mapel D, Pace W, Carter V, Couper A, Drummond MB, Feigler N, Federman A, Gandhi H, Hanania NA, Kaplan A, Kostikas K, Kruszyk M, van Melle M, Müllerová H, Murray R, Ohar J, Pollack M, Pullen R, Williams D, Wisnivesky J, Han MK, Meldrum C, Price D. Kerr M, et al. Among authors: feigler n. Lancet Reg Health Am. 2023 Jul 28;24:100546. doi: 10.1016/j.lana.2023.100546. eCollection 2023 Aug. Lancet Reg Health Am. 2023. PMID: 37545746 Free PMC article.
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
Martinez FJ, Han MK, Lopez C, Murray S, Mannino D, Anderson S, Brown R, Dolor R, Elder N, Joo M, Khan I, Knox LM, Meldrum C, Peters E, Spino C, Tapp H, Thomashow B, Zittleman L, Make B, Yawn BP; CAPTURE Study Group. Martinez FJ, et al. JAMA. 2023 Feb 14;329(6):490-501. doi: 10.1001/jama.2023.0128. JAMA. 2023. PMID: 36786790 Free PMC article.
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study.
Evans KA, Pollack M, Portillo E, Strange C, Touchette DR, Staresinic A, Patel S, Tkacz J, Feigler N. Evans KA, et al. Among authors: feigler n. J Manag Care Spec Pharm. 2022 Dec;28(12):1366-1377. doi: 10.18553/jmcp.2022.28.12.1366. J Manag Care Spec Pharm. 2022. PMID: 36427341 Free PMC article.
13 results